Boehringer Ingelheim Initiates SPRING Study Of Aptivus® (tipranavir) In Diverse Group Of Highly Tre - Details

Link Details 

+ Articles ON » Listing Details

User Menu

» Articles Home
» Submit Article Link
» Submit Feed
» Latest Articles
» Top Articles



Statistics

Categories: 160
Subcategories: 0
Total Posts/Links: 3622
Pending: 1
Today: 0


Sponsors


» BlogsON
» Law Blogs
» A-Law Directory
» Hukuki Net law
» Webdeweb





ID:536
Title:Boehringer Ingelheim Initiates SPRING Study Of Aptivus® (tipranavir) In Diverse Group Of Highly Tre - http://www.medicalnewstoday.com/medicalnews.php?newsid=74290&nfid=crss
Description:Boehringer Ingelheim GmbH announced that it has begun to enroll patients in the SPRING study. The SPRING study will be one of the largest racially and gender diverse international studies of highly treatment-experienced HIV-1 infected patients. The trial will examine the safety, efficacy and pharmacokinetics of Aptivus® (tipranavir) in a racially diverse group of 200 female and 200 male treatment-experienced patients across eight countries in three continents. [click link for full article]
Category:Aids
Link Owner:
Date Added:June 16, 2007 03:00:00 PM
Number Hits:0
 
RSS Feed